Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0T0LE
|
||||
Former ID |
DIB001852
|
||||
Drug Name |
IRX-4310
|
||||
Synonyms |
AGN-194310; AGN-4310; ALRT-4310; LGD-4310; NRX-4310; RARa antagonist (oral, chemotherapy-induced neutropenia), Io Therapeutics; Retinoic acid receptor alpha antagonist (oral, chemotherapy-induced neutropenia), Io Therapeutics
|
||||
Indication | Psoriasis [ICD9: 696; ICD10:L40] | Discontinued in Phase 3 | [546671] | ||
Company |
Io Therapeutics Inc
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
C1(=CC(Sc2c1cc(C#Cc1ccc(C(=O)O)cc1)cc2)(C)C)c1ccc(cc1)C<br />C
|
||||
CAS Number |
CAS 229961-45-9
|
||||
Target and Pathway | |||||
Target(s) | Retinoic acid receptor | Target Info | Antagonist | [527142] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.